Germline and somatic mutations in prostate cancer: Implications for treatment.

Abstract excerpt

Genetic testing is an integral part of the workup of metastatic prostate cancer, in part, because the results can have a profound impact on the subsequent management of this disease. There are now several Food & Drug Administration (FDA) approved therapeutics available for patients with prostate cancer and certain genetic abnormalities - most notably, mutations in DNA damage repair (DDR) pathways such mismatch...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genetic Testing
• Share to Germ-Line Mutation
• Share to Mutation